603108 XD润达医疗
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-1.6031.2806.69111.36511.408
总资产报酬率 ROA (%)-0.4890.3861.8963.1493.427
投入资产回报率 ROIC (%)-0.6090.4842.4384.0574.315

边际利润分析
销售毛利率 (%)20.77925.36526.55427.99026.998
营业利润率 (%)-2.9554.2607.0717.7798.779
息税前利润/营业总收入 (%)0.9137.92810.62910.89412.100
净利润/营业总收入 (%)-4.0842.2794.8396.2426.752

收益指标分析
经营活动净收益/利润总额(%)68.80091.73975.566103.84189.673
价值变动净收益/利润总额(%)-42.42831.78235.39016.72017.666
营业外收支净额/利润总额(%)-0.782-2.4651.3350.4000.341

偿债能力分析
流动比率 (X)1.2261.2201.2481.1541.204
速动比率 (X)1.0221.0441.0650.9640.961
资产负债率 (%)61.00160.82561.93465.49463.450
带息债务/全部投入资本 (%)59.43659.92760.04463.45261.096
股东权益/带息债务 (%)64.41462.95863.12155.09559.836
股东权益/负债合计 (%)50.04650.04548.29340.89245.416
利息保障倍数 (X)0.2372.1023.0703.5333.676

营运能力分析
应收账款周转天数 (天)274.517232.505225.516165.206136.520
存货周转天数 (天)96.11978.35480.18674.27673.918